Peter Thornton
Chief Financial Officer, Agenus.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Avadel Pharmaceuticals AVDL0 shares4Feb 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 12, 2026Returned to company 115,060 shares at $21.00 of Avadel Pharmaceuticals4
- Jul 29, 2025Granted 11,000 shares of Avadel Pharmaceuticals5
- Jan 13, 2025Bought 10,000 shares at $8.05 of Avadel Pharmaceuticals6
- Jul 30, 2024Granted 11,000 shares of Avadel Pharmaceuticals7
- May 27, 2022Bought 50,000 shares at $1.69 of Avadel Pharmaceuticals8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAvadel Pharmaceuticals, Board member
- 2SEC EDGARAgenus, Board member
- 3SEC EDGARAgenus, Chief financial officer
- 4
- 5SEC EDGARForm 4 filed Jul 31, 2025
- 6SEC EDGARForm 4 filed Jan 14, 2025
- 7SEC EDGARForm 4 filed Aug 1, 2024
- 8SEC EDGARForm 4 filed May 31, 2022